Status:
COMPLETED
A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Impotence
Eligibility:
MALE
30+ years
Phase:
PHASE4
Brief Summary
To compare the efficacy and safety of Viagra (sildenafil citrate) vs. placebo for the treatment of men with ED and at least 1 prespecified risk factor who do not self identify as having ED.
Eligibility Criteria
Inclusion
- Men who do not identify as having ED with documented ED
- Men 30 years of age and older
- At least one prespecified risk factor for ED
Exclusion
- Subjects currently prescribed, taking and/or likely to be treated with nitrates or nitric oxide donors in any form on either a regular or intermittent basis
- Subjects with a known history of retinitis pigmentosa.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
371 Patients enrolled
Trial Details
Trial ID
NCT00343200
Start Date
July 1 2006
End Date
September 1 2007
Last Update
February 1 2021
Active Locations (48)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Huntsville, Alabama, United States, 35801
2
Pfizer Investigational Site
Mesa, Arizona, United States, 85213
3
Pfizer Investigational Site
Phoenix, Arizona, United States, 85023
4
Pfizer Investigational Site
Phoenix, Arizona, United States, 85051